North America Women's Health Market Size & Outlook
Related Markets
North America women's health market highlights
- The North America women's health market generated a revenue of USD 21,230.0 million in 2024.
- The market is expected to grow at a CAGR of 3.9% from 2025 to 2030.
- In terms of segment, contraceptives was the largest revenue generating application in 2024.
- Menopause is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 21,230.0 million |
| Market revenue in 2030 | USD 27,843.3 million |
| Growth rate | 3.9% (CAGR from 2025 to 2030) |
| Largest segment | Contraceptives |
| Fastest growing segment | Menopause |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Hormonal Infertility, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS) |
| Key market players worldwide | AbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring |
Other key industry trends
- In terms of revenue, North America region accounted for 43.0% of the global women's health market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 17,554.4 million by 2030.
Contraceptives was the largest segment with a revenue share of 37.17% in 2024. Horizon Databook has segmented the North America women's health market based on postmenopausal osteoporosis, endometriosis & uterine fibroids, hormonal infertility, contraceptives, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in the population of older women in the region is one of the key factors driving the demand for women’s health products in North America. More than 15% of the women in North America are above the age of 65 years.
Moreover, increasing prevalence of osteoporosis in postmenopausal women is a key factor expected to drive the demand for women’s health products, including drugs and devices. Increase in the number of market approvals of women’s health drugs and high healthcare expenditure are among the factors contributing to market growth.
For instance, in May 2023, the U.S. FDA approved Veozah (fezolinetant) to reduce the frequency and severity of hot flashes in menopause. Moreover, in May 2020, AbbVie’s Oriahnn received FDA approval. It is an oral medication indicated for heavy menstrual bleeding due to uterine fibroids.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Women's Health Market Scope
Women's Health Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Apothecus | View profile | 11-50 | Hicksville, New York, United States, North America | https://apothecus.com |
| Blairex Laboratories | View profile | 101-250 | Columbus, Indiana, United States, North America | http://www.blairex.com |
| Agile Therapeutics Inc | View profile | 19 | 500 College Road East, Suite 310, Princeton, NJ, United States, 08540 | https://www.agiletherapeutics.com |
| Ferring | View profile | 5001-10000 | Saint-prex, Vaud, Switzerland, Europe | https://www.ferring.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
North America women's health market size, by country, 2018-2030 (US$M)
North America Women's Health Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
